|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 44.28 USD | -3.45% |
|
+0.18% | +1.03% |
| 26/03 | Recursion Pharmaceuticals Announces Executive Changes, Effective April 6, 2026 | CI |
| 12/03 | Exelixis, Inc. Presents at Barclays 28th Annual Global Healthcare Conference, Mar-11-2026 12:00 PM |
| Capitalization | 11.5B 9.74B 8.98B 8.47B 15.8B 1,072B 16.05B 105B 41.24B 515B 43.14B 42.24B 1,827B | P/E ratio 2026 * |
14.5x | P/E ratio 2027 * | 11.9x |
|---|---|---|---|---|---|
| Enterprise value | 10.48B 8.87B 8.18B 7.72B 14.39B 977B 14.62B 95.97B 37.57B 469B 39.3B 38.48B 1,665B | EV / Sales 2026 * |
4.06x | EV / Sales 2027 * | 3.22x |
| Free-Float |
98.21% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Exelixis, Inc.
| 1 day | -3.45% | ||
| 1 week | +0.18% | ||
| Current month | +3.24% | ||
| 1 month | +7.37% | ||
| 3 months | -2.55% | ||
| 6 months | +10.62% | ||
| Current year | +1.03% |
| 1 week | 43.75 |  | 46.1 |
| 1 month | 40.84 | | 46.1 |
| Current year | 39.71 | | 46.31 |
| 1 year | 33.76 | | 49.62 |
| 3 years | 18.08 | | 49.62 |
| 5 years | 14.87 | | 49.62 |
| 10 years | 4.23 | | 49.62 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 22/07/2010 | |
| Director of Finance/CFO | 58 | 15/07/2015 | |
Dana Aftab
COO | Chief Operating Officer | 63 | 01/02/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 69 | 01/02/2004 | |
George Poste
BRD | Director/Board Member | 82 | 01/08/2004 |
| Chairman | 77 | 01/01/1998 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -10.91% | 13.24% | 253 M€ | |
| -.--% | 2.62% | 1 M€ | |
| -.--% | 1.67% | 4 M€ | |
| -.--% | 1.59% | 2 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.45% | +0.18% | +21.18% | +127.54% | 11.91B | |
| +0.71% | +5.88% | +33.96% | +104.43% | 51.73B | |
| +0.26% | +2.98% | +103.18% | +24.51% | 47.14B | |
| -4.34% | -8.39% | +106.47% | +776.06% | 33.11B | |
| +1.08% | +8.03% | +0.47% | -23.28% | 24.89B | |
| +1.24% | +5.40% | +85.45% | -30.76% | 19.66B | |
| -0.22% | +2.82% | +42.23% | -34.72% | 17.86B | |
| 0.00% | +8.78% | +76.11% | +236.91% | 16.22B | |
| +1.29% | +12.28% | -14.22% | +1,245.22% | 16.17B | |
| -1.45% | +5.42% | +76.99% | - | 14.44B | |
| Average | -0.49% | +4.44% | +53.18% | +269.55% | 25.31B | |
| Weighted average by Cap. | -0.35% | +3.43% | +59.10% | +234.38% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.58B 2.19B 2.02B 1.9B 3.55B 241B 3.61B 23.66B 9.26B 116B 9.69B 9.49B 410B | 2.93B 2.48B 2.29B 2.16B 4.03B 273B 4.09B 26.85B 10.51B 131B 11B 10.77B 466B |
| Net income | 802M 680M 627M 591M 1.1B 74.79B 1.12B 7.35B 2.88B 35.91B 3.01B 2.95B 127B | 984M 834M 769M 725M 1.35B 91.72B 1.37B 9.01B 3.53B 44.03B 3.69B 3.61B 156B |
| Net Debt | -1.02B -867M -800M -754M -1.41B -95.43B -1.43B -9.38B -3.67B -45.81B -3.84B -3.76B -163B | -2.06B -1.74B -1.61B -1.51B -2.82B -192B -2.87B -18.84B -7.37B -92.02B -7.71B -7.55B -327B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/04/26 | 44.28 $ | -3.45% | 2,187,847 |
| 14/04/26 | 45.86 $ | +2.00% | 2,533,407 |
| 13/04/26 | 44.96 $ | +1.56% | 2,224,775 |
| 10/04/26 | 44.27 $ | -2.51% | 2,945,426 |
| 09/04/26 | 45.41 $ | +2.74% | 1,813,072 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- EXEL Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition